Health Care & Life Sciences » Biotechnology | Zealand Pharma A/S

Zealand Pharma A/S | Cash Flow

Fiscal year is January-December. All values DKK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
183,676.00
64,990.00
113,957.00
153,910.00
272,271.00
581,282
Depreciation, Depletion & Amortization
5,911.00
5,932.00
6,215.00
5,410.00
4,757.00
4,508
Other Funds
-
-
-
-
507,500.00
1,058,975
Funds from Operations
165,975.00
58,954.00
86,542.00
104,762.00
264,455.00
473,185
Changes in Working Capital
3,643.00
16,771.00
138,871.00
153,452.00
14,291.00
12,785
Net Operating Cash Flow
169,618.00
42,183.00
225,413.00
48,690.00
278,746.00
460,400
Capital Expenditures
4,569.00
4,497.00
4,040.00
2,600.00
7,226.00
Sale of Fixed Assets & Businesses
-
-
-
-
120.00
Purchase/Sale of Investments
101,394.00
24,383.00
27.00
24.00
84,349.00
Net Investing Cash Flow
96,808.00
19,763.00
4,013.00
2,624.00
91,494.00
Issuance/Reduction of Debt, Net
-
272,170.00
-
-
176,360.00
Net Financing Cash Flow
-
272,170.00
96,413.00
157,146.00
337,930.00
Net Change in Cash
72,669.00
252,095.00
98,074.00
209,654.00
47,457.00
Free Cash Flow
174,187.00
46,680.00
229,453.00
46,090.00
285,972.00
Change in Capital Stock
-
-
96,413.00
157,146.00
6,790.00
Exchange Rate Effect
141.00
2,345.00
34,939.00
6,442.00
15,147.00
Other Uses
17.00
123.00
-
-
39.00

About Zealand Pharma A/S

View Profile
Address
Smedeland 36
Glostrup ZE 2600
Denmark
Employees -
Website http://www.zealandpharma.com
Updated 07/08/2019
Zealand Pharma A/S is a biotechnology company that engages in the discovery, design, and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark.